Form Bio Blog

Updates and perspectives from our industry experts, scientists and product leaders.

Category
Sort Date
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Maximizing Therapeutic Efficacy Through Codon Substitution Design
Featured
Vector Design

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Sasha Maslova

Sasha Maslova

Get insights from Sasha, our Artificial Intelligence (AI) Scientist, on a newly published article describing the potential undesirable effects of synonymous codon substitution and the role of computational methods to overcome these challenges.

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing
Featured
Biomanufacturing

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Jill Roughan, PhD

Jill Roughan, PhD

Single-cell analysis techniques and multi-omics are providing a newfound understanding of hidden complexity in biological systems, revolutionizing the biomanufacturing process for cell and gene therapies. Here’s how.

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers
Featured
Artificial Intelligence

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Austin Day, PhD

Austin Day, PhD

Continuing our blog series on Transformer architectures and their use in gene therapy applications, we explore the latest variants’ size and speed improvements.

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs
Featured
Vector Design

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs

Nick Ketz, PhD

Nick Ketz, PhD

Transformer based architectures are uniquely efficient and powerful when used to process structured data. Read this blog to learn how they can be customized, adapted and applied to AAV construct optimization.

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials
Featured
Vector Design

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials

Jill Roughan, PhD

Jill Roughan, PhD

In this article, we take a look at the role of viral vectors in gene therapy clinical trials, including current challenges and leveraging artificial intelligence to advance the field.

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development
Featured
Bioinformatics

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development

Jill Roughan, PhD

Jill Roughan, PhD

Want to know more about the foundational types and common tools to use for RNA-Seq data visualization in gene therapy development? Read this blog to find out.

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies
Featured
Bioinformatics

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies

Jill Roughan, PhD

Jill Roughan, PhD

Since their discovery, CRISPR-Cas systems have changed and evolved. Read about how base, prime, and RNA editing are driving new therapeutic applications.

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy
Featured
Artificial Intelligence

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy

Jill Roughan, PhD

Jill Roughan, PhD

As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs
Featured
Biomanufacturing

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Nick Ketz, PhD

Nick Ketz, PhD

DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.

How to leverage natural history studies to fill knowledge gaps in cell and gene therapy development
Featured

How to leverage natural history studies to fill knowledge gaps in cell and gene therapy development

Claire Aldridge, PhD

Claire Aldridge, PhD

Why are natural history studies important in cell and gene therapy development? Hear from our Chief Strategy Officer, Claire Aldridge, PhD on the importance of these studies and the need for effective data capture to make the most of them.

How Computational Life Sciences Enables Metagenomics Studies
Featured
Bioinformatics

How Computational Life Sciences Enables Metagenomics Studies

Jill Roughan, PhD

Jill Roughan, PhD

Metagenomics studies and sophisticated computational tools advance disciplines from basic research to healthcare. Find out more in our blog.

Guest Post: What 2023 Holds for Cell and Gene Therapy
Featured
Artificial Intelligence

Guest Post: What 2023 Holds for Cell and Gene Therapy

ChatGPT

ChatGPT

With AI becoming not just inextricable but central for both science and software, we thought it fitting and worthwhile to utilize creative AI tools to see what 2023 might have in store for cell and gene therapy. Hence, our guest author is none other than OpenAI's ChatGPT.

Form Bio Resources

Board of Directors

Doe

Johnnn

Doe

,

Ph.D.

CEO
Doe

John

Doe

,

Ph.D.

CEO
Doe

Johnnn

Doe

,

Ph.D.

CEO
Doe

Johnn

Doe

,

Ph.D.

CEO

Form Bio Resources